Stocks Health care VRXA
NASDAQ · Health careVeraxa Biotech Holding AG (VRXA)
We have not processed filings for Veraxa Biotech Holding AG yet. This page fills in on its own once we have read them.
Key facts about Veraxa Biotech Holding AG
- Net worth
- Veraxa Biotech Holding AG has a market value (market cap) of $151.3M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on June 16, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What Veraxa Biotech Holding AG does
Veraxa Biotech Holding AG is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker VRXA.
Earnings: every quarter and the next report date
Latest SEC filings
What Veraxa Biotech Holding AG has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 15, 2026
- September 4, 2026
- August 24, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 5, 2026
- August 5, 2026
- July 31, 2026
- July 31, 2026
- July 31, 2026
- July 27, 2026
Insider trades
What the people running Veraxa Biotech Holding AG did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $125.3K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 28, 2026 | Gruninger MarcDirector | Bought | 9,133 | $9.1K |
| October 27, 2026 | Gruninger MarcDirector | Bought | 867 | $849.7 |
| October 20, 2026 | Ziegler Christoph SamuelDirector | Bought | 30,000 | $32.7K |
| August 27, 2026 | Antz Christoph RudigerChief Executive Officer, Director | Bought | 5,000 | $7.7K |
| August 27, 2026 | Baumann Oliver RolfDirector | Boughtindirect | 50,000 | $75K |
Who owns VRXA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
4 insiders reported holding 5,826,550 shares in total, about $6.2M at the last price.
| Holder | Shares |
|---|---|
| Baumann Oliver RolfDirector | 5,773,6185,773,618 held indirectly |
| Ziegler Christoph SamuelDirector | 37,932 |
| Gruninger MarcDirector | 10,000 |
| Antz Christoph RudigerChief Executive Officer, Director | 5,000 |
Questions about VRXA
What does Veraxa Biotech Holding AG do?
Veraxa Biotech Holding AG is a company in the Health care sector, listed on NASDAQ as VRXA. Its shares trade on NASDAQ under the ticker VRXA.
What is Veraxa Biotech Holding AG's net worth?
Veraxa Biotech Holding AG has a market value (market cap) of $151.3M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
When did Veraxa Biotech Holding AG last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on June 16, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the insider trade from October 29, 2026.
Similar companies
Compare VRXA with
Follow VRXA
Get an email when Veraxa Biotech Holding AG files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Veraxa Biotech Holding AG tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.